Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001828750-22-000001
Filing Date
2022-11-17
Accepted
2022-11-17 13:26:53
Documents
1
Effectiveness Date
2022-11-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12727
  Complete submission text file 0001828750-22-000001.txt   13759
Mailing Address 30301 AGOURA ROAD, #210 AGOURA HILLS CA 91301
Business Address 30301 AGOURA ROAD, #210 AGOURA HILLS CA 91301 805-491-1988
A2 Biotherapeutics, Inc. (Filer) CIK: 0001828750 (see all company filings)

EIN.: 822253911 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-465076 | Film No.: 221397525